A new study shows that people Zepbound lost about 50% more weight than those using Wegovy. It was the first head-to-head ...

Norway's wealth fund, the world's largest, has sold all its fixed income investments in Mexican state oil firm Pemex, it said ...

Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as ...

Allison Stange lost 40 pounds since starting Zepbound in April 2024, improving both her blood pressure and sleep apnea. Now ...

Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies.

A US judge on Thursday rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk's popular diabetes and weight-loss drugs Ozempic and Wegovy while a legal ... Lilly's weight-loss ...

and Zepbound, which continue to outpace Novo’s Wegovy in efficacy. Together, they are driving projected 2025 revenues of $58 billion to $61 billion, potentially surpassing the $59.2 billion ...

A federal judge in Texas late Thursday rejected a bid by compounding pharmacies to keep making copies of Ozempic and Wegovy while a ... in its weight loss drug Zepbound and diabetes treatment ...

The ruling means that small-scale compounders must immediately stop making their versions of Novo’s Ozempic and Wegovy ... blockbusters Mounjaro and Zepbound, as another lawsuit plods on.

Pharmaceutical companies like Novo Nordisk and Eli Lilly took the world by storm last year with a new generation of so-called GLP-1 diet products - Ozempic, Wegovy and Zepbound. The drugs were ...